Carmell Therapeutics Corporation (CTCX)
NASDAQ: CTCX · IEX Real-Time Price · USD
2.050
-0.020 (-0.97%)
At close: May 17, 2024, 3:59 PM
2.340
+0.290 (14.15%)
After-hours: May 17, 2024, 5:11 PM EDT
Carmell Therapeutics Market Cap
Carmell Therapeutics has a market cap or net worth of $45.19 million as of May 17, 2024. Its market cap has decreased by -77.56% in one year.
Market Cap
45.19M
Enterprise Value
45.84M
1-Year Change
-77.56%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since July 27, 2021, Carmell Therapeutics's market cap has decreased from $192.10M to $45.19M, a decrease of -76.47%. That is a compound annual growth rate of -40.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 42.60M | -10.13% |
May 16, 2024 | 47.40M | -2.27% |
May 15, 2024 | 48.50M | 16.03% |
May 14, 2024 | 41.80M | -0.48% |
May 13, 2024 | 42.00M | 6.33% |
May 10, 2024 | 39.50M | -5.95% |
May 9, 2024 | 42.00M | 6.06% |
May 8, 2024 | 39.60M | 0.25% |
May 7, 2024 | 39.50M | 1.54% |
May 6, 2024 | 38.90M | -8.04% |
May 3, 2024 | 42.30M | 7.09% |
May 2, 2024 | 39.50M | - |
May 1, 2024 | 39.50M | 2.60% |
Apr 30, 2024 | 38.50M | - |
Apr 29, 2024 | 38.50M | -4.23% |
Apr 26, 2024 | 40.20M | - |
Apr 25, 2024 | 40.20M | 3.88% |
Apr 24, 2024 | 38.70M | -8.51% |
Apr 23, 2024 | 42.30M | 6.28% |
Apr 22, 2024 | 39.80M | 4.74% |
Apr 19, 2024 | 38.00M | -12.04% |
Apr 18, 2024 | 43.20M | 2.13% |
Apr 17, 2024 | 42.30M | - |
Apr 16, 2024 | 42.30M | -8.84% |
Apr 15, 2024 | 46.40M | -6.26% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aligos Therapeutics | 49.52M |
Reviva Pharmaceuticals Holdings | 48.02M |
Gain Therapeutics | 47.66M |
Cutera | 47.47M |
LENSAR | 47.30M |
Aadi Bioscience | 47.14M |
Autonomix Medical | 47.03M |
iCAD, Inc. | 46.67M |